Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| 1 |
Microsoft
MSFT
|
+$3.51B |
| 2 |
Apple
AAPL
|
+$3.37B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.74B |
| 4 |
Amazon
AMZN
|
+$1.74B |
| 5 |
Eli Lilly
LLY
|
+$1.35B |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.79B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.75B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$702M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$612M |
| 5 |
Energy Select Sector SPDR Fund
XLE
|
+$576M |
Sector Composition
| 1 | Technology | 17.33% |
| 2 | Healthcare | 12.11% |
| 3 | Financials | 10.61% |
| 4 | Consumer Discretionary | 8.09% |
| 5 | Industrials | 6.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRFT
1151
DELISTED
Perficient Inc
PRFT
| $81.9M | 0.01% |
1,172,504
+661,997
| +130% | +$46.2M |
|
1152
STMicroelectronics
STM
$23.1B
| $81.8M | 0.01% |
2,300,657
-121,966
| -5% | -$4.34M |
|
1153
Camden Property Trust
CPT
$11.7B
| $81.8M | 0.01% |
730,932
-80,328
| -10% | -$8.99M |
|
1154
Goldman Sachs Future Tech Leaders Equity ETF
GTEK
$183M
| $81.7M | 0.01% |
3,906,500
+493,450
| +14% | +$10.3M |
|
1155
Goldman Sachs Future Health Care Equity ETF
GDOC
$19.6M
| $81.5M | 0.01% |
2,593,777
-309,300
| -11% | -$9.72M |
|
1156
Cohen & Steers Tax-Advantaged Preferred Securities & Income Fund
PTA
$1.14B
| $81.5M | 0.01% |
4,614,676
+103,027
| +2% | +$1.82M |
|
|
IBDP
1157
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
| $81.5M | 0.01% |
3,335,748
+53,547
| +2% | +$1.31M |
|
1158
Insight Enterprises
NSIT
$3.9B
| $81.4M | 0.01% |
811,951
+476,084
| +142% | +$47.7M |
|
1159
Check Point Software Technologies
CHKP
$21B
| $81.3M | 0.01% |
644,770
+75,826
| +13% | +$9.57M |
|
1160
iShares US Oil & Gas Exploration & Production ETF
IEO
$469M
| $81.3M | 0.01% |
875,832
+34,597
| +4% | +$3.21M |
|
1161
Herbalife
HLF
$986M
| $81.3M | 0.01% |
5,463,022
+2,757,443
| +102% | +$41M |
|
1162
BlackRock Enhanced Global Dividend Trust
BOE
$650M
| $81.2M | 0.01% |
8,498,156
-517,465
| -6% | -$4.95M |
|
1163
Independent Bank
INDB
$3.56B
| $81.2M | 0.01% |
961,843
+688,062
| +251% | +$58.1M |
|
|
GSFP
1164
DELISTED
Goldman Sachs Future Planet Equity ETF
GSFP
| $81.2M | 0.01% |
2,765,977
-172,100
| -6% | -$5.05M |
|
1165
Houlihan Lokey
HLI
$14.4B
| $81.2M | 0.01% |
931,264
+522,178
| +128% | +$45.5M |
|
1166
CyberArk
CYBR
$23.5B
| $81.1M | 0.01% |
625,621
-8,204
| -1% | -$1.06M |
|
|
GBUY
1167
DELISTED
Goldman Sachs Future Consumer Equity ETF
GBUY
| $81.1M | 0.01% |
3,488,371
+224,500
| +7% | +$5.22M |
|
1168
Minerals Technologies
MTX
$1.99B
| $81M | 0.01% |
1,334,204
+1,064,915
| +395% | +$64.7M |
|
1169
Victoria's Secret
VSCO
$2.12B
| $81M | 0.01% |
2,263,928
-583,298
| -20% | -$20.9M |
|
|
ARNC
1170
DELISTED
Arconic Corporation
ARNC
| $81M | 0.01% |
3,826,023
+228,875
| +6% | +$4.84M |
|
|
NARI
1171
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $81M | 0.01% |
1,273,630
+1,019,378
| +401% | +$64.8M |
|
|
AZEK
1172
DELISTED
The AZEK Co
AZEK
| $80.7M | 0.01% |
3,973,475
+2,906,460
| +272% | +$59.1M |
|
1173
Globus Medical
GMED
$7.93B
| $80.7M | 0.01% |
1,086,289
-123,962
| -10% | -$9.21M |
|
1174
Quaker Houghton
KWR
$2.46B
| $80.5M | 0.01% |
482,199
+361,525
| +300% | +$60.3M |
|
1175
Bio-Rad Laboratories Class A
BIO
$7.59B
| $80.4M | 0.01% |
191,121
+53,491
| +39% | +$22.5M |
|